See more : BankInvest BIX DK Akt Ansvarlig (BAIBDKAAUA.CO) Income Statement Analysis – Financial Results
Complete financial analysis of MyndTec Inc. (MYTC.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MyndTec Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Arlington Asset Investment Corp. (AAIC) Income Statement Analysis – Financial Results
- Bajaj Auto Limited (BAJAJ-AUTO.NS) Income Statement Analysis – Financial Results
- Prestige Consumer Healthcare Inc. (PBH) Income Statement Analysis – Financial Results
- Golden Goliath Resources Ltd. (GNG.V) Income Statement Analysis – Financial Results
- Ningbo David Medical Device Co., Ltd. (300314.SZ) Income Statement Analysis – Financial Results
MyndTec Inc. (MYTC.CN)
About MyndTec Inc.
MyndTec Inc., a medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States. Its flagship product is MyndMove, a non-invasive functional electrical stimulation-based intervention that uses neuroplasticity mechanisms to stimulate the development of new neural efferent and afferent pathways allowing patients to re-establish voluntary movement and improve independence in their activities of daily living, as well as offers trained therapists the ability to assist individuals affected with paralysis to enhance voluntary control of their limbs. The company offers MyndMove or MyndSearch devices to clinics and research institutions, as well as sells treatment supplies. It serves hospitals through direct sales, as well as a network of distributors. The company was formerly known as Simple Systems Inc. and changed its name to MyndTec Inc. in April 2013. MyndTec Inc. was incorporated in 2008 and is headquartered in Mississauga, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 137.31K | 255.80K | 605.57K | 162.63K |
| Cost of Revenue | 82.42K | 188.36K | 250.95K | 95.59K |
| Gross Profit | 54.90K | 67.44K | 354.62K | 67.04K |
| Gross Profit Ratio | 39.98% | 26.37% | 58.56% | 41.22% |
| Research & Development | 324.25K | 414.74K | 726.30K | 556.62K |
| General & Administrative | 905.84K | 1.21M | 2.37M | 1.24M |
| Selling & Marketing | 98.55K | 100.35K | 90.32K | 291.82K |
| SG&A | 1.00M | 1.31M | 2.46M | 1.53M |
| Other Expenses | -1.27M | 372.70K | -124.92K | -314.35K |
| Operating Expenses | 54.90K | 2.10M | 3.06M | 1.77M |
| Cost & Expenses | 137.31K | 2.29M | 3.31M | 1.87M |
| Interest Income | 0.00 | 8.05K | 576.00 | 0.00 |
| Interest Expense | 23.46K | 114.89K | 319.55K | 228.29K |
| Depreciation & Amortization | 121.19K | 131.60K | 106.03K | 120.23K |
| EBITDA | -1.58M | -1.88M | -2.62M | -1.15M |
| EBITDA Ratio | -1,149.71% | -737.18% | -435.32% | -922.48% |
| Operating Income | 0.00 | -2.02M | -2.74M | -1.62M |
| Operating Income Ratio | 0.00% | -788.63% | -452.83% | -996.41% |
| Total Other Income/Expenses | -1.72M | -114.89K | -306.90K | 126.00K |
| Income Before Tax | -1.72M | -2.13M | -3.05M | -1.49M |
| Income Before Tax Ratio | -1,255.05% | -833.54% | -503.51% | -918.93% |
| Income Tax Expense | 0.00 | 114.89K | 286.18K | 314.51K |
| Net Income | -1.72M | -2.25M | -3.34M | -1.81M |
| Net Income Ratio | -1,255.05% | -878.46% | -550.77% | -1,112.32% |
| EPS | -0.07 | -0.11 | -0.15 | -0.08 |
| EPS Diluted | -0.07 | -0.11 | -0.15 | -0.08 |
| Weighted Avg Shares Out | 23.60M | 21.23M | 21.84M | 21.84M |
| Weighted Avg Shares Out (Dil) | 23.60M | 21.23M | 21.84M | 21.84M |
Source: https://incomestatements.info
Category: Stock Reports